125 related articles for article (PubMed ID: 32353391)
21. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract][Full Text] [Related]
22. Incidence and patterns of retropharyngeal lymph node involvement in oropharyngeal carcinoma.
Iyizoba-Ebozue Z; Murray LJ; Arunsingh M; Vaidyanathan S; Scarsbrook AF; Prestwich RJD
Radiother Oncol; 2020 Jan; 142():92-99. PubMed ID: 31431388
[TBL] [Abstract][Full Text] [Related]
23. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
Fodor A; Berardi G; Fiorino C; Picchio M; Busnardo E; Kirienko M; Incerti E; Dell'Oca I; Cozzarini C; Mangili P; Pasetti M; Calandrino R; Gianolli L; Di Muzio NG
BJU Int; 2017 Mar; 119(3):406-413. PubMed ID: 27104782
[TBL] [Abstract][Full Text] [Related]
24.
Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
[TBL] [Abstract][Full Text] [Related]
25. The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer.
Wang YJ; Huang CY; Hou WH; Wang CC; Lan KH; Chen CH; Yu HJ; Lai MK; Cheng AL; Liu SP; Pu YS; Cheng JC
World J Surg Oncol; 2015 Nov; 13():312. PubMed ID: 26545980
[TBL] [Abstract][Full Text] [Related]
26. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates.
De Bruycker A; De Bleser E; Decaestecker K; Fonteyne V; Lumen N; De Visschere P; De Man K; Delrue L; Lambert B; Ost P
Eur Urol; 2019 May; 75(5):826-833. PubMed ID: 30503072
[TBL] [Abstract][Full Text] [Related]
27. Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy.
Peabody H; Lane BR; Qi J; Kim T; Montie JE; Moriarity A; Brede CM; Montgomery J;
World J Urol; 2021 Mar; 39(3):779-785. PubMed ID: 32361876
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer.
Brenneman RJ; Goddu SM; Andruska N; Roy A; Bosch WR; Fischer-Valuck B; Efstathiou JA; Gay HA; Michalski JM; Baumann BC
Pract Radiat Oncol; 2022; 12(2):e117-e122. PubMed ID: 34695615
[TBL] [Abstract][Full Text] [Related]
29. Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
Müller AC; Eckert F; Paulsen F; Zips D; Stenzl A; Schilling D; Alber M; Bares R; Martus P; Weckermann D; Belka C; Ganswindt U
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):263-71. PubMed ID: 26853335
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.
Daouacher G; von Below C; Gestblom C; Ahlström H; Grzegorek R; Wassberg C; Sörensen J; Waldén M
BJU Int; 2016 Jul; 118(1):77-83. PubMed ID: 26074275
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles.
Winter A; Kowald T; Paulo TS; Goos P; Engels S; Gerullis H; Schiffmann J; Chavan A; Wawroschek F
Int J Nanomedicine; 2018; 13():6689-6698. PubMed ID: 30425483
[TBL] [Abstract][Full Text] [Related]
32. Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.
Passoni NM; Suardi N; Abdollah F; Picchio M; Giovacchini G; Messa C; Freschi M; Montorsi F; Briganti A
Urol Oncol; 2014 Jan; 32(1):38.e9-16. PubMed ID: 23769269
[TBL] [Abstract][Full Text] [Related]
33. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.
Vogel MME; Düsberg M; Stöhrer L; Dewes S; Sage EK; Borm KJ; Gschwend JE; Eiber M; Combs SE; Schiller K
Eur Urol Oncol; 2022 Dec; 5(6):668-676. PubMed ID: 36280446
[TBL] [Abstract][Full Text] [Related]
35. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.
Vargas CE; Galalae R; Demanes J; Harsolia A; Meldolesi E; Nürnberg N; Schour L; Martinez A
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1474-82. PubMed ID: 15964706
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer.
Akasu T; Iinuma G; Takawa M; Yamamoto S; Muramatsu Y; Moriyama N
Ann Surg Oncol; 2009 Oct; 16(10):2787-94. PubMed ID: 19618244
[TBL] [Abstract][Full Text] [Related]
37. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.
Pinaquy JB; De Clermont-Galleran H; Pasticier G; Rigou G; Alberti N; Hindie E; Mokrane Y; Fernandez P
Prostate; 2015 Feb; 75(3):323-31. PubMed ID: 25393215
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.
Lonati C; Mordasini L; Afferi L; De Cobelli O; Di Trapani E; Necchi A; Colombo R; Briganti A; Montorsi F; Simeone C; Zamboni S; Simone G; Karnes RJ; Marra G; Soria F; Gontero P; Shariat SF; Pradere B; Hendricksen K; Ammiwala M; Rink M; Poyet C; Krajewski W; Baumeister P; Mattei A; Moschini M; Carando R;
Urol Oncol; 2022 May; 40(5):195.e27-195.e35. PubMed ID: 35236621
[TBL] [Abstract][Full Text] [Related]
40. Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging.
Zhuang Z; Ma X; Zhang Y; Yang X; Wei M; Deng X; Wang Z
Int J Colorectal Dis; 2022 Sep; 37(9):2069-2083. PubMed ID: 36028723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
